STOK Stoke Therapeutics Forecast, Technical & Fundamental Analysis
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the bodys potential with RNA medicine... Show more
STOK is expected to report earnings to fall 2.75% to -76 cents per share on August 10
Q2'26
Est.
$-0.77
Q1'26
Beat
by $0.02
Q4'25
Missed
by $0.23
Q3'25
Missed
by $0.07
Q2'25
Beat
by $0.10
The last earnings report on May 07 showed earnings per share of -79 cents, beating the estimate of -81 cents. With 569.52K shares outstanding, the current market capitalization sits at 1.87B.
A.I. Advisor
published General Information
General Information
a company, which engages in the research and development of treatments for genetic diseases.
A.I.dvisor indicates that over the last year, STOK has been loosely correlated with QTTB. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if STOK jumps, then QTTB could also see price increases.
STOK sees its Stochastic Oscillator climbs out of oversold territory
On June 05, 2026, the Stochastic Oscillator for STOK moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 47 instances where the indicator left the oversold zone. In of the 47 cases the stock moved higher in the following days. This puts the odds of a move higher at over .
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where STOK's RSI Oscillator exited the oversold zone, of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on June 05, 2026. You may want to consider a long position or call options on STOK as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for STOK just turned positive on June 04, 2026. Looking at past instances where STOK's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where STOK advanced for three days, in of 302 cases, the price rose further within the following month. The odds of a continued upward trend are .
STOK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The 10-day moving average for STOK crossed bearishly below the 50-day moving average on May 01, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where STOK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for STOK entered a downward trend on May 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. STOK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.733) is normal, around the industry mean (19.817). P/E Ratio (48.338) is within average values for comparable stocks, (36.300). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.691). STOK has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.039). P/S Ratio (56.497) is also within normal values, averaging (355.038).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STOK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
